Clinical trial
A Concordance Study Comparing Insulin Treatments in Patients With Type 2…
NCT00330473 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00330473 |
|---|---|
| Title | A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes |
| Official title | A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Human Insulin Inhalation Powder, Insulin |
| Enrollment | 1,019 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 26, 2006 |
| Last update posted | Sep 16, 2019 |
| Countries | Argentina, Brazil, Canada, Denmark, India, Mexico, Poland, Puerto Rico, Russia, South Africa, South Korea, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: